GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Institutional Ownership

IPA (ImmunoPrecise Antibodies) Institutional Ownership : 4.17% (As of Apr. 22, 2025)


View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ImmunoPrecise Antibodies's institutional ownership is 4.17%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ImmunoPrecise Antibodies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ImmunoPrecise Antibodies's Float Percentage Of Total Shares Outstanding is 99.33%.


ImmunoPrecise Antibodies Institutional Ownership Historical Data

The historical data trend for ImmunoPrecise Antibodies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Institutional Ownership Chart

ImmunoPrecise Antibodies Historical Data

The historical data trend for ImmunoPrecise Antibodies can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 0.06 0.06 0.06 0.06 0.06 0.04 0.03 0.03 0.02 0.02

ImmunoPrecise Antibodies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.